Sadick M D, Galloway A, Shelton D, Hale V, Weck S, Anicetti V, Wong W L
Department of BioAnalytical Technology, Genentech, Inc., South San Francisco, California 94080, USA.
Exp Cell Res. 1997 Aug 1;234(2):354-61. doi: 10.1006/excr.1997.3614.
A rapid, sensitive, and high-capacity assay has been developed to quantify ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a "kinase receptor activation" or KIRA-ELISA, utilizes two separate microtiter plates, one for cell culture and ligand stimulation, and the other for receptor capture and phosphotyrosine ELISA. The assay was developed for analysis of neurotrophin-induced trkA, trkB, or trkC activation. It utilizes a trkA, trkB, or trkC receptor fused with a 26-amino-acid polypeptide flag derived from HSV glycoprotein D (gD.trkA, B, or C, respectively) on the amino-terminus, stably transfected into CHO cells. Stimulated receptors were solubilized with Triton X-100 buffer and then captured in ELISA wells coated with gD-specific mAb. The degree of receptor autophosphorylation was quantified by anti-phosphotyrosine ELISA. Reproducible standard curves were generated with an EC50 of approximately 16 ng/ml NGF for gD.trkA KIRA, 11 ng/ml for NT4/5 and 20 ng/ml for BDNF in gD.trkB KIRA, and 9.4 ng/ml for NT3 in gD.trkC KIRA. When the gD.trkA KIRA assay was used to quantify serum NGF or NT3 following administration to rats, the assay agreed well with currently existing ELISA assays. When the gD.trkA KIRA assay was used to test several NGF variants, as well as NGF stability samples, the capacity of the assay to quantify ligand bioactivity compared well with the more widely used radioreceptor binding and PC 12 cell survival assays. The gD.trk KIRA assays show great potential as rapid bioassays, capable of quantitative, consistent, and stability indicating analyses.
已开发出一种快速、灵敏且高通量的检测方法,用于根据受体磷酸化来定量配体诱导的受体酪氨酸激酶激活。该检测方法被称为“激酶受体激活”或KIRA-ELISA,它使用两个单独的微量滴定板,一个用于细胞培养和配体刺激,另一个用于受体捕获和磷酸酪氨酸ELISA。该检测方法是为分析神经营养因子诱导的trkA、trkB或trkC激活而开发的。它利用在氨基末端与源自单纯疱疹病毒糖蛋白D的26个氨基酸的多肽标签(分别为gD.trkA、B或C)融合的trkA、trkB或trkC受体,稳定转染到CHO细胞中。受刺激的受体用Triton X-100缓冲液溶解,然后捕获在包被有gD特异性单克隆抗体的ELISA孔中。通过抗磷酸酪氨酸ELISA定量受体自磷酸化程度。对于gD.trkA KIRA,用约16 ng/ml NGF生成可重复的标准曲线;对于gD.trkB KIRA,NT4/5为11 ng/ml,BDNF为20 ng/ml;对于gD.trkC KIRA,NT3为9.4 ng/ml。当使用gD.trkA KIRA检测方法来定量给大鼠给药后的血清NGF或NT3时,该检测方法与现有的ELISA检测方法结果吻合良好。当使用gD.trkA KIRA检测方法测试几种NGF变体以及NGF稳定性样本时,该检测方法定量配体生物活性的能力与更广泛使用的放射受体结合和PC 12细胞存活检测方法相比表现良好。gD.trk KIRA检测方法作为快速生物检测方法具有很大潜力,能够进行定量、一致且表明稳定性的分析。